Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey

J Cancer Res Ther. 2012 Jan-Mar;8(1):62-7. doi: 10.4103/0973-1482.95176.

Abstract

Context: Renal graft recipients who develop post-transplant lymphoproliferative disorders (PTLD) that complicate bone marrow (BM).

Aims: To investigate features, predictors and prognosis of BM involvement by PTLD in renal transplant patients.

Settings and design: A comprehensive search for the available data though PubMed and Google Scholar for reports of PTLD localization in BM in renal allograft recipients.

Materials and methods: Data of 168 PTLD cases in renal transplant context who have developed bone marrow PTLD gathered from 18 studies and were pooled and analyzed.

Statistical analysis used: Chi-square test, Student's t test and fissure's exact test were employed.

Results: Chi-square test showed that renal recipients with BM PTLD were significantly more likely to represent multi-organ disease (P<0.001), and disseminated PTLD (P<0.001). BM PTLD was also more frequently seen among pediatric renal recipients who had developed PTLD (P=0.016). PTLD, in BM PTLD renal recipients more significantly complicated liver (P=0.008), but less commonly affected skin (P=0.045). BM PTLD lesions were relatively more likely to be of monomorph phenomenon (P=0.06).

Conclusions: Renal recipients with BM PTLD represent worse outcome and more unfavorable histopathological phenomenon than in other organ involvements. Moreover, a concomitant PTLD involvement site in liver was found which necessitates full hepatic evaluation for a potential complication by the disease in renal recipients whose BM is involved.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone Marrow / pathology*
  • Female
  • Humans
  • Kidney Transplantation / adverse effects*
  • Lymphoproliferative Disorders / etiology*
  • Lymphoproliferative Disorders / mortality
  • Lymphoproliferative Disorders / pathology*
  • Male
  • Middle Aged
  • Prognosis
  • Survival Analysis